Jing Zou

Jing Zou

Auto-generated profile, based on publicly available information

Jing Zou

Department of Microbiology and Immunology, University of Texas Medical Branch

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HXHongjie Xia
Hongjie Xia
XXXuping Xie
Xuping Xie
JZJing Zou
Jing Zou
CNChristian G. Noble
Christian G. Noble
WRWilliam K. Russell
William K. Russell
PSPei-Yong Shi
Pei-Yong Shi
Significance: DENV represents the most important mosquito-borne viral pathogen in humans. Although one dengue vaccine has been approved for clinical use, its efficacies against serotypes 1 and 2 remain to be improved. No effective anti-DENV therapy is available for patient treatment. In this study, we solved the cocrystal structure of the DENV-2 capsid protein in complex with an inhibitor that preferentially inhibits serotype 2 (not the other three serotypes) in vitro and in vivo. Mechanistically, the compound is incorporated into virions by inducing capsid tetramerization. Such inhibitor-containing virions are defective in nucleocapsid uncoating when infecting new cells. Our results have also uncovered the resistance mechanism and provided a high-resolution structure for rational design of capsid inhibitors with pan-serotype DENV activity.

28 March 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YWYan Wang
Yan Wang
LSLong Sun
Long Sun
LFLuciana De Souza Fernandes
Luciana De Souza Fernandes
Yu-Hsiu WangYu-Hsiu Wang
Yu-Hsiu Wang
JZJing Zou
Jing Zou
XXXuping Xie
Xuping Xie
Dengue, caused by the dengue virus (DENV), presents a significant public health challenge with limited effective treatments. NITD-688 is a potent panserotype DENV inhibitor currently in Phase II clinical trials. However, its mechanism of action is not fully understood. Here, we present the molecular details of how NITD-688 inhibits DENV. NITD-688 binds directly to the nonstructural protein 4B (NS4B) with nanomolar affinities across all four DENV serotypes and specifically disrupts the interaction between NS4B and nonstructural protein 3 (NS3) without significantly changing the interactions between NS4B and other viral or host proteins. NS4B mutations that confer resistance to NITD-688 reduce both NITD-688 binding to NS4B and disruption of the NS4B/NS3 interaction. Specifically, NITD-688 blocks the interaction of NS3 with a cytosolic loop within NS4B. This inhibits the formation of new NS4B/NS3 complexes and disrupts preexisting complexes in vitro and DENV-infected cells, ultimately inhibiting viral replication. Consistent with this mechanism, NITD-688 retains greater potency in cellular assays with delayed treatment compared to JNJ-1802, another NS4B inhibitor that has been studied in Phase II clinical trials. Together, these findings provide critical insights into the mechanism of action of NITD-688, facilitating the development of novel flavivirus NS4B inhibitors and informing future clinical interventions against DENV.

12 January 2023 in Emerging Microbes & Infections
Verified
Journal Article
Open access
HXHongjie Xia
Hongjie Xia
JYJason Yeung
Jason Yeung
BKBirte Kalveram
Birte Kalveram
CBCody J. Bills
Cody J. Bills
JCJohn Yun-Chung Chen
John Yun-Chung Chen
PSPei-Yong Shi
Pei-Yong Shi
The rapid evolution of SARS-CoV-2 Omicron sublineages mandates a better understanding of viral replication and cross-neutralization among these sublineages. Here we used K18-hACE2 mice and primary human airway cultures to examine the viral fitness and antigenic relationship among Omicron sublineages. In both K18-hACE2 mice and human airway cultures, Omicron sublineages exhibited a replication order of BA.5 ≥ BA.2 ≥ BA.2.12.1 > BA.1; no difference in body weight loss was observed among different sublineage-infected mice. The BA.1-, BA.2-, BA.2.12.1-, and BA.5-infected mice developed distinguishable cross-neutralizations against Omicron sublineages, but exhibited little neutralization against the index virus (i.e. USA-WA1/2020) or the Delta variant. Surprisingly, the BA.5-infected mice developed higher neutralization activity against heterologous BA.2 and BA.2.12.1 than that against homologous BA.5; serum neutralizing titres did not always correlate with viral replication levels in infected animals. Our results revealed a distinct antigenic cartography of Omicron sublineages and support the bivalent vaccine approach.

1 July 2011
Verified
Conference Paper
Closed access
JZJing Zou
Jing Zou
DLDong-Dai Lin
Dong-Dai Lin
GMGuo-Cui Mi
Guo-Cui Mi
Due to the parallel nature of brute force attack, it is well suited to use parallel or distributed computing to recover passwords encrypted by one-way hash functions. When distributing the password cracking task between threads or nodes, it is necessary to divide the search space into several subspaces. It is ideal that the size of these subspaces is the same for a load balanced solution. However, increasing the length of passwords will raise the number of combinations exponentially. This will raises issues for the search space uniform partition. This paper presents a universal distributed model for password cracking capable of dividing the search space evenly. For this, the paper addresses the definition of a base-n-like number, and discusses operations on it and relations with base-n number. The model is data independent, easily implemented and needs a few of communications. Experimental results are then shown.